Phillips 66
260.78USD
+1.6400 (+0.63%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $9.52▲ | $6.21 | 10 | 4 |
| Next quarter | $6.61▲ | $4.74 | 12 | 2 |
| Current year | $25.67▲ | $17.88 | 16 | 0 |
| Next year | $21.3▲ | $17.07 | 14 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $7.5 | $9.41 | +1.91 (+25.5%) |
| 2026-03-31 | $-0.39 | $0.49 | +0.88 (+225.7%) |
| 2025-12-31 | $2.15 | $2.47 | +0.32 (+14.7%) |
| 2025-09-30 | $2.16 | $2.52 | +0.36 (+16.8%) |
386 ratings from 29 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Buy | $235 $300 | Sep 8, 2026 |
| Piper Sandler | Maintained | Neutral | $209 $264 | Sep 3, 2026 |
| Wells Fargo | Maintained | Overweight | $239 $335 | Sep 1, 2026 |
| Piper Sandler | Maintained | Neutral | $208 $209 | Aug 10, 2026 |
| TD Cowen | Maintained | Buy | $240 $255 | Aug 6, 2026 |
| Wells Fargo | Maintained | Overweight | $201 $239 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $200 $220 | Aug 6, 2026 |
| Barclays | Maintained | Equal-Weight | $183 $216 | Aug 6, 2026 |
| UBS | Maintained | Buy | $212 $235 | Jul 27, 2026 |
| Goldman Sachs | Maintained | Neutral | $207 $235 | Jul 22, 2026 |
| TD Cowen | Maintained | Buy | $220 $240 | Jul 21, 2026 |
| Citigroup | Maintained | Neutral | $183 $204 | Jul 14, 2026 |
| Evercore ISI Group | Maintained | Outperform | $195 $200 | Jul 13, 2026 |
| Raymond James | Maintained | Outperform | $218 $235 | Jul 13, 2026 |
| Jefferies | Maintained | Hold | $191 $207 | Jul 9, 2026 |
| Barclays | Maintained | Equal-Weight | $177 $183 | Jul 9, 2026 |
| TD Cowen | Maintained | Buy | $213 $220 | Jun 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $180 $196 | Jun 12, 2026 |
| Mizuho | Upgraded from Neutral | Outperform | $170 $212 | May 27, 2026 |
| Goldman Sachs | Maintained | Neutral | $192 $207 | May 20, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $147 $174 | Apr 24, 2026 |
| Scotiabank | Maintained | Sector Perform | $140 $151 | Apr 22, 2026 |
| Citigroup | Maintained | Neutral | $159 $183 | Apr 9, 2026 |
| Barclays | Maintained | Equal-Weight | $158 $177 | Apr 8, 2026 |
| Piper Sandler | Maintained | Neutral | $168 $177 | Apr 8, 2026 |
104 filings from 26 insiders · 14 buy / 11 sell over 6m
Officers and directors of PSX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HARBISON RICHARD GOfficer | Exercise | 52.1k | $74.70 | $4.72M | Aug 12, 2026 |
| HARBISON RICHARD GOfficer | Sell | 52.1k | $223.76 | $11.66M | Aug 12, 2026 |
| MANDELL BRIANOfficer | Exercise | 33.3k | $74.70 | $2.49M | Aug 11, 2026 |
| MANDELL BRIANOfficer | Sell | 33.3k | $214.02 | $7.16M | Aug 11, 2026 |
| KLUPPEL ANN M.Officer | Exercise | 7.8k | $89.05 | $742k | Aug 10, 2026 |
| DAVIS LISA ANNDirector | Sellindirect | 1.5k | $207.21 | $315k | Aug 10, 2026 |
| KLUPPEL ANN M.Officer | Sell | 7.8k | $205.00 | $1.65M | Aug 10, 2026 |
| SUTHERLAND VANESSA ALLENGeneral Counsel | Sell | 4.1k | $208.80 | $854k | Jul 21, 2026 |
| SUTHERLAND VANESSA ALLENGeneral Counsel | Sell | 3.5k | $211.05 | $744k | Jul 21, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Exercise | 11.0k | $94.97 | $1.05M | Jul 9, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Sell | 11.0k | $190.03 | $2.09M | Jul 9, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Exercise | 30.0k | $94.85 | $2.85M | May 11, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Sell | 30.0k | $170.00 | $5.10M | May 11, 2026 |
| MEYERS KEVIN OMARDirector | Buy | 175 | $173.12 | $30k | May 6, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Exercise | 15.6k | $94.97 | $1.48M | Mar 30, 2026 |
| MITCHELL KEVIN JChief Financial Officer | Sell | 15.6k | $190.07 | $2.97M | Mar 30, 2026 |
| MEYERS KEVIN OMARDirector | Buy | 175 | $173.20 | $30k | Mar 17, 2026 |
| UNGERLEIDER HOWARD I.Director | Grant | 949 | $172.84 | $164k | Mar 16, 2026 |
| MEYERS KEVIN OMARDirector | Grant | 949 | $172.84 | $164k | Mar 16, 2026 |
| DAVIS LISA ANNDirector | Sell | 3.8k | $174.37 | $663k | Mar 13, 2026 |
No analyst notes on PSX yet.
Analyst Ratings
19 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 6 | 2 | 0 | Buy2.35 |
| 1 mo ago | 3 | 9 | 6 | 1 | 1 | Buy2.40 |
| 2 mo ago | 3 | 9 | 6 | 1 | 1 | Buy2.40 |
| 3 mo ago | 3 | 9 | 6 | 1 | 0 | Buy2.26 |